Please ensure Javascript is enabled for purposes of website accessibility

Md. firm gets $25M contract for nerve agent countermeasure (access required)

The U.S. State Department gave a one-year contract worth up to $25 million to Emergent BioSolutions Inc. of Gaithersburg to supply a drug and auto-injector that can be used to counter nerve agent or organophosphate. The drug, Trobigard, is designed to be administered into muscles prior to going to a hospital. The contract also has a six-month option. Emergent will ...

To purchase a reprint of this article, contact [email protected].